# Novavax (stock symbol: NVAX) Logo in transparent PNG and SVG formats

## Novavax Logo large

### Novavax Logo large Download PNG (48.26 KB)

![Novavax Logo large Download PNG (48.26 KB)](/img/orig/NVAX_BIG-2c9f8457.png)

### Novavax Logo large Download SVG (10.56 KB)

![Novavax Logo large Download SVG (10.56 KB)](/img/orig/NVAX_BIG-2566bae3.svg)

## Novavax Logo icon format

### Novavax Logo icon format Download PNG (55.14 KB)

![Novavax Logo icon format Download PNG (55.14 KB)](/img/orig/NVAX-37654a61.png)

### Novavax Logo icon format Download SVG (8.58 KB)

![Novavax Logo icon format Download SVG (8.58 KB)](/img/orig/NVAX-e4abe99b.svg)

## Novavax Logo large for dark backgrounds

### Novavax Logo large for dark backgrounds Download PNG (26.86 KB)

![Novavax Logo large for dark backgrounds Download PNG (26.86 KB)](/img/orig/NVAX_BIG.D-20ef90a8.png)

### Novavax Logo large for dark backgrounds Download SVG (10.52 KB)

![Novavax Logo large for dark backgrounds Download SVG (10.52 KB)](/img/orig/NVAX_BIG.D-d8840995.svg)

## Novavax Logo icon format for dark backgrounds

### Novavax Logo icon format for dark backgrounds Download PNG (26.72 KB)

![Novavax Logo icon format for dark backgrounds Download PNG (26.72 KB)](/img/orig/NVAX.D-9196e0b3.png)

### Novavax Logo icon format for dark backgrounds Download SVG (8.58 KB)

![Novavax Logo icon format for dark backgrounds Download SVG (8.58 KB)](/img/orig/NVAX.D-89eac37c.svg)

## About Novavax

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

1. Website domain: novavax.com
2. Employees: 1541
3. Marketcap: $0.66 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
